Business Wire

Hy Stor Energy Strategic Partnership with Key Gulf Coast Port Becomes First to Deliver Renewable Hydrogen Access for Manufacturing, Industrial Applications, Port Operations and Long Duration Energy Storage

29.6.2022 16:00:00 EEST | Business Wire | Press release

Share

Hy Stor Energy LP (Hy Stor Energy), a company pioneering renewably produced green hydrogen and energy storage at scale in Mississippi, announced today a strategic partnership with the Hancock County Port and Harbor Commission (HCPHC) to provide zero-carbon, zero-methane hydrogen to Port Bienville Industrial Park and Stennis International Airport, accelerating the decarbonization of land, air, sea, and space. Through this partnership, Port Bienville will be the first port in the Gulf Region to integrate renewable hydrogen as a fuel into its operations. During the first phase of the partnership, the hydrogen hub is expected to produce an estimated 350 tons/day (320,000 kg/day) of renewable hydrogen and store more than 71,000 tons (69 million kg) of hydrogen in underground salt caverns.

The existing Port Bienville infrastructure will expand to better enable decarbonization efforts and will be in a premium location to allow for new manufacturing of circular hydrogen infrastructure – the first of its kind in the United States. Port customers striving to meet their respective ESG goals will be able to create new industry jobs – strengthening the port’s position as a workforce hub of industry and technology.

Together Hy Stor Energy and HCPHC will work to sustain economic growth in Hancock County and provide reliable, renewable, and carbon-free energy to coastal Mississippi and the Gulf Coast Region. Currently, Port Bienville Industrial Park is home to leading companies including SABIC Innovative Plastics, DAK Americas, SNF Polychemie, Calgon Carbon, and Jindal Tubular USA, among others.

“Hancock County Port and Harbor Commission is committed to growing economic opportunities in a responsible way,” said CEO Bill Cotter, HCPHC. “Hydrogen is emerging as a way to cut carbon emissions in energy-intensive sectors like manufacturing and transportation. As we continue to grow our maritime, rail and aerospace operations, hydrogen provides options to fuel growth and innovations.”

Hancock County, Mississippi, is located in a prime position on the Gulf Coast with access to inland waterways, rail, and highway corridors. Located a short distance east of New Orleans, Hancock County is home to Port Bienville, Stennis International Airport, and NASA’s John C. Stennis Space Center, which enable domestic and global reach. Hy Stor Energy will develop the renewable hydrogen from its Clean Hydrogen Hub from offices in Jackson, Gulfport, and Kiln at Port Bienville.

“We are proud to partner with the Hancock County Port and Harbor Commission to provide renewable hydrogen access to Port Bienville Industrial Park, including some of the world’s most recognized companies,” said Laura L. Luce, CEO of Hy Stor Energy. “This partnership provides a strategic opportunity for companies who are looking for innovative ways to meet their decarbonization goals to co-locate operations in Hancock County in the Gulf Region. We are focused on developing zero-carbon, zero-methane renewable hydrogen technology for a broad array of applications, including manufacturing and industrial processes, port operations, and long-duration energy storage that will benefit communities while providing reliable clean power.”

The Richton Dome in Perry County, Mississippi was a previously selected expansion location for the U.S. Strategic Petroleum Reserve, and its central U.S. and Gulf Coast location will serve as a Strategic Hydrogen Reserve connected to new, dedicated, dual bi-directional pipelines that will extend from Richton in Perry County to Hancock County and the Port of Bienville. Hy Stor Energy’s infrastructure will enable 24x7 renewable green hydrogen to be delivered to and from the port in addition to underground salt storage domes within approximately 100 miles of the port – providing resilient, zero-carbon, zero-methane hydrogen on demand. These long-term renewable hydrogen storage salt domes in Richton will be interconnected to new pipeline infrastructure and will further connect multiple salt domes from Louisiana to Jackson, Mississippi to Simpson County to Smith County to Perry County - and on to Hancock County to provide resilient, clean energy to coastal communities as well. This will allow Mississippi to serve as a U.S. centrally located and highly connected strategic hydrogen reserve to connect multiple underground salt domes with Richton where the first salt dome caverns will be developed purpose-built for the safe storage of renewable hydrogen at scale.

For more information about Hy Stor Energy, please visit www.hystorenergy.com.

About Hy Stor Energy

Hy Stor Energy is facilitating the transition to a fossil-free energy environment by developing and advancing renewable hydrogen at scale through the development, commercialization, and operation of renewable hydrogen hub projects. The company defines green hydrogen as only that which has produced from renewables -- as set forth by the Green Hydrogen Organisation. Large, fully integrated projects produce, store, and deliver 100% carbon-free, energy, providing customers with safe and reliable renewable energy on-demand. Developed as part of an integrated hub, these projects couple on-site renewable hydrogen production with integrated long-duration storage and distribution – using scale to reduce costs. Hy Stor Energy, led by energy storage industry and hydrogen technology veteran Laura L. Luce, has an innovative team with deep expertise and is positioned as a leader in the renewable hydrogen revolution. For more information, please visit www.hystorenergy.com.

About Hancock County Port and Harbor Commission

The Hancock County Port and Harbor Commission was established in 1963 to lead the county’s economic development activities. Stennis International Airport and Port Bienville Industrial Park are home to 30 companies with more than 1,000 employees. For more information visit www.portairspace.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Hy Stor Energy Media Contact
Brad Carl
On behalf of Hy Stor Energy
brad@teamsilverline.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 14:30:00 EEST | Press release

Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye